Opko Health Inc (OPK)

[Fishing at Surfside]

From an article from 9/5/2006 regarding Froptix

"If such a drug could be engineered and delivered early in the course of the disease, it may rescue and preserve the retina from further damage, the researchers believe.

Kaushal and his group are systematically testing each of the 40 to 45 new molecules in animal models. Earlier this year, Kaushal was among a group who formed an opthalmic pharmaceutical company, Froptix, to advance the drug development process.

"Two years ago, we didn't have anything," Kaushal said. "Now we are hoping to be in a position to develop a meaningful clinical trial in early 2007."

http://www.ocusource.com/main.cfm?page=info&topic=pressroom&article=569